Biomarker diagnostic tests in precision medicine can stratify patient sub-populations into responders versus non-responders. Precision medicine’s promise is selecting the right drug for the ...
Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...
New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.
The accurate early detection and precise localization of diseases remain pivotal challenges in modern medicine. Traditional diagnostic methods often grapple ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
Molecular biomarkers, such as variations in genetic sequences, protein levels, or combinations of specific biochemical changes, are increasingly important to the emergence of personalized medicine.
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project Several studies have indicated that broad ...
MENLO PARK, Calif.--(BUSINESS WIRE)--HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, a global leader ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback